Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
peginesatide (Omontys) (2012 NDA)
darbepoetin alfa (aranesp) (2 trials)
epoetin (Epogen) (4 trials)
methoxy polyethylene glycol-epoetin beta (Mircera) (1 trial)
peginesatide (Omontys) (17 trials)
Anemia (Phase 3)
Kidney Diseases (Phase 3)
Kidney Failure, Chronic (Phase 3)
Renal Insufficiency (Phase 3)
Renal Insufficiency, Chronic (Phase 3)
Trials (17 total)
Trial APIs (4 total)